153 related articles for article (PubMed ID: 19557131)
1. Detection of the antiviral drug oseltamivir in aquatic environments.
Söderström H; Järhult JD; Olsen B; Lindberg RH; Tanaka H; Fick J
PLoS One; 2009 Jun; 4(6):e6064. PubMed ID: 19557131
[TBL] [Abstract][Full Text] [Related]
2. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
Ghosh GC; Nakada N; Yamashita N; Tanaka H
Environ Health Perspect; 2010 Jan; 118(1):103-7. PubMed ID: 20056566
[TBL] [Abstract][Full Text] [Related]
3. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.
Järhult JD; Muradrasoli S; Wahlgren J; Söderström H; Orozovic G; Gunnarsson G; Bröjer C; Latorre-Margalef N; Fick J; Grabic R; Lennerstrand J; Waldenström J; Lundkvist A; Olsen B
PLoS One; 2011; 6(9):e24742. PubMed ID: 21931841
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.
Järhult JD
Infect Ecol Epidemiol; 2012; 2():. PubMed ID: 22957124
[TBL] [Abstract][Full Text] [Related]
5. Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak.
Azuma T; Nakada N; Yamashita N; Tanaka H
Environ Sci Technol; 2012 Dec; 46(23):12873-81. PubMed ID: 23106220
[TBL] [Abstract][Full Text] [Related]
6. Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan.
Azuma T; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Sato T; Yamashita N; Tanaka H; Mino Y
PLoS One; 2015; 10(6):e0131412. PubMed ID: 26110817
[TBL] [Abstract][Full Text] [Related]
7. Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak.
Azuma T; Nakada N; Yamashita N; Tanaka H
Chemosphere; 2013 Nov; 93(9):1672-7. PubMed ID: 23871592
[TBL] [Abstract][Full Text] [Related]
8. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus.
Fick J; Lindberg RH; Tysklind M; Haemig PD; Waldenström J; Wallensten A; Olsen B
PLoS One; 2007 Oct; 2(10):e986. PubMed ID: 17912363
[TBL] [Abstract][Full Text] [Related]
9. Potential risks associated with the proposed widespread use of Tamiflu.
Singer AC; Nunn MA; Gould EA; Johnson AC
Environ Health Perspect; 2007 Jan; 115(1):102-6. PubMed ID: 17366827
[TBL] [Abstract][Full Text] [Related]
10. Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic.
Leknes H; Sturtzel IE; Dye C
Sci Total Environ; 2012 Jan; 414():632-8. PubMed ID: 22127154
[TBL] [Abstract][Full Text] [Related]
11. Prediction, risk and control of anti-influenza drugs in the Yodo River Basin, Japan during seasonal and pandemic influenza using the transmission model for infectious disease.
Azuma T; Nakada N; Yamashita N; Tanaka H
Sci Total Environ; 2015 Jul; 521-522():68-74. PubMed ID: 25828414
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants.
Ghosh GC; Nakada N; Yamashita N; Tanaka H
Chemosphere; 2010 Sep; 81(1):13-7. PubMed ID: 20692015
[TBL] [Abstract][Full Text] [Related]
13. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters.
Bartels P; von Tümpling W
Sci Total Environ; 2008 Nov; 405(1-3):215-25. PubMed ID: 18675443
[TBL] [Abstract][Full Text] [Related]
14. Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems.
Saccà ML; Accinelli C; Fick J; Lindberg R; Olsen B
Chemosphere; 2009 Mar; 75(1):28-33. PubMed ID: 19124147
[TBL] [Abstract][Full Text] [Related]
15. Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.
Gillman A; Muradrasoli S; Söderström H; Holmberg F; Latorre-Margalef N; Tolf C; Waldenström J; Gunnarsson G; Olsen B; Järhult JD
Appl Environ Microbiol; 2015 Apr; 81(7):2378-83. PubMed ID: 25616792
[TBL] [Abstract][Full Text] [Related]
16. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
17. Meeting report: risk assessment of tamiflu use under pandemic conditions.
Singer AC; Howard BM; Johnson AC; Knowles CJ; Jackman S; Accinelli C; Caracciolo AB; Bernard I; Bird S; Boucard T; Boxall A; Brian JV; Cartmell E; Chubb C; Churchley J; Costigan S; Crane M; Dempsey MJ; Dorrington B; Ellor B; Fick J; Holmes J; Hutchinson T; Karcher F; Kelleher SL; Marsden P; Noone G; Nunn MA; Oxford J; Rachwal T; Roberts N; Roberts M; Saccà ML; Sanders M; Straub JO; Terry A; Thomas D; Toovey S; Townsend R; Voulvoulis N; Watts C
Environ Health Perspect; 2008 Nov; 116(11):1563-7. PubMed ID: 19057712
[TBL] [Abstract][Full Text] [Related]
18. Antiviral pandemic risk assessment for urban receiving waters.
Ellis JB
Water Sci Technol; 2010; 61(4):879-84. PubMed ID: 20182065
[TBL] [Abstract][Full Text] [Related]
19. A measure of resistance: detecting Tamiflu metabolite in sewage discharge and river water.
Tillett T
Environ Health Perspect; 2010 Jan; 118(1):A34. PubMed ID: 20061221
[No Abstract] [Full Text] [Related]
20. Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River.
Singer AC; Johnson AC; Anderson PD; Snyder SA
Environ Health Perspect; 2008 Jul; 116(7):A285-A286. PubMed ID: 18629328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
